Santarus Announces Appellate Court Reversal in Part of ZEGERID Invalidity Decision

Santarus, Inc. today announced that the U.S. Court of Appeals for the Federal Circuit reversed in part a lower court decision of invalidity involving certain asserted patent claims covering ZEGERID® Capsules and ZEGERID Powder for Oral Suspension.

Posted in Uncategorized